Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), awd decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 fold » _ fold (Expand Search), 5 fold (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), awd decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 fold » _ fold (Expand Search), 5 fold (Expand Search)
-
1621
Differential gene expression in WT and ESAM-KO pre CFU-E fraction after 5-FU treatment.
Published 2016“…(C) Venn diagram of the 65 genes that are shared between the genes that have more than a 2-fold increased or decreased expression in ESAM-KO pre CFU-E compared to WT pre CFU-E, and the “erythropoiesis”-related genes. …”
-
1622
-
1623
Differential expression patterns and functional gene groups associated with SARS-CoV-2 infection of nose organoids.
Published 2025“…<p><b>(a)</b> HNO204 human nose organoids were infected with SARS-CoV-2 at an MOI of 0.01, and samples at 6hrs, 72hrs, and 6 days post infection were profiled for gene expression. …”
-
1624
-
1625
Attenuation of spheroid size decrease or MUC5AC increase by hit compounds.
Published 2023“…<p>Final hit compounds (with hit concentration and corresponding target) that <b>A)</b> increased bronchosphere size compared to DMSO + 3% CSE control bronchospheres or <b>B)</b> decreased secreted MUC5AC. …”
-
1626
Drugs which cluster on the 'anxiolytic' group decrease 5-HT turnover in the brain.
Published 2014“…<p>(A) Turnover rates, as measured by 5-HIAA:5-HT ratios, normalized to the values of vehicle-treated animals, for the following drugs: fluoxetine (FLX; chronic treatment with 10 mg/kg); chlordiazepoxide (CDZ; 0.02 mg/kg); clonazepam (CLZ; 0.05 mg/kg); diazepam (DZP; 1.25 mg/kg); buspirone (BUS; 50 mg/kg); ethanol (EtOH, 2.5%); dizocilpine (MK; 0.005 mg/kg); verapamil (VER; 5 mg/kg); WAY 100,635 (WAY; 0.03 mg/kg); and SB 224,289 (SB; 2.5 mg/kg). …”
-
1627
-
1628
Nimodipine does not decrease markers of neuritic dystrophy in 5XFAD transgenic mice.
Published 2022“…<p><b>(</b>A and F) Representative immunoblots of hippocampal (A) and cortical (F) lysates of non-transgenic and 5XFAD mice treated with vehicle or nimodipine. …”
-
1629
<i>Hem1<sup>−/−</sup></i> erythrocytes contain increased phospho-adducin and decreased levels of essential membrane skeletal proteins.
Published 2013“…(D) Erythrocyte ghosts from <i>Hem1<sup>−/−</sup></i> mice contain increased PP2A catalytic subunit (PP2Ac) and decreased PP2A regulatory subunit (PP2Ar) protein relative to WT erythrocytes. …”
-
1630
-
1631
-
1632
Loss of Pcgf5 results in reduction in global H2AK119 levels.
Published 2016“…The representative data from two independent experiments are presented. (B) Scatter plots showing the correlation of the fold enrichment values against the input signals (ChIP/input) (transcription start site ± 2.0 kb) of H2AK119ub1 and H3K27me3 of RefSeq genes (listed in RefSeq ID) between WT and <i>Pcgf5</i><sup><i>Δ/Δ</i></sup> GMPs. …”
-
1633
VGB treatment decreased the number of GFAP positive cells in hippocampus of <i>Tsc1</i><sup>GFAP</sup>CKO mice.
Published 2013“…(B) Quantitative analysis demonstrated a 2–2.5 fold increase in GFAP-positive cell in vehicle-treated <i>Tsc1</i><sup>GFAP</sup>CKO group (KO + Veh) compared with vehicle-treated control group (Cont + Veh) in neocortex (CT), dentate gyrus (DG) and CA1 of hippocampus. …”
-
1634
-
1635
-
1636
-
1637
-
1638
Wounds treated with sDll4-Fc have increased vascular density but decreased vascular maturation in direct proportion to the dosage level.
Published 2012“…C,D,E) Representative anti-PECAM and anti-SMA immunofluorescence images of neo-vasculature in granulation tissue of wounds treated with (D) 0,05 mg/kg or (E) 2,5 mg/kg compared with control mice injected with PBS (C), in days 2, 4 and 6. sDll4-Fc therapy leads to decreased smooth muscle cell recruitment and increased vascular density that is directly proportional to the administered dosage. * In graphics represents p<0,05.…”
-
1639
-
1640